China Shineway Pharmaceutical Group Limited (HKG:2877)

HKG:2877 Revenue

China Shineway Pharmaceutical Group had revenue of 1.18B CNY in the half year ending June 30, 2026, a decrease of -43.40%. This brings the company's revenue in the last twelve months to 2.66B, down -20.34% year-over-year. In the year 2025, China Shineway Pharmaceutical Group had annual revenue of 3.14B, down -17.01%. That makes China Shineway Pharmaceutical Group the 12,664th largest company in the world by revenue and 759th in Hong Kong.

• Revenue (ttm): 2.66B CNY
• Revenue Growth: -20.34%
• P/S Ratio: 1.82
• Revenue / Employee: 1.00M CNY
• Employees: 2,656
• Market Cap: 5.61B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.14B	-642.62M	-17.01%
Dec 31, 2024	3.78B	-738.50M	-16.35%
Dec 31, 2023	4.52B	565.90M	14.32%
Dec 31, 2022	3.95B	727.09M	22.56%
Dec 31, 2021	3.22B	567.85M	21.38%

Data Source: S&P Global Market Intelligence Last updated: Sep 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 8, 2026

Data Sources Report a data error